Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Daiichi Sankyo

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,354,760

« Back to Dashboard

Summary for Patent: 5,354,760

Title: Crystalline Tiagabine monohydrate, its preparation and use
Abstract:The invention provides crystalline Tiagabine hydrochloride monohydrate, process for its preparation, compositions containing the same and its therapeutic use as anti-epileptic agent.
Inventor(s): Petersen; Henning (Lyngby, DK), Nielsen; Peter (Herlev, DK), Cain; Michael (Grayslake, IL), Patel; Subhash (Chicago, IL)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:07/857,038
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,354,760

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark0582/91Apr 02, 1991

International Patent Family for Patent: 5,354,760

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany69229339► Subscribe
Denmark58291► Subscribe
Denmark0579681► Subscribe
European Patent Office0579681► Subscribe
Spain2134801► Subscribe
Finland934298► Subscribe
Canada2107223► Subscribe
Australia1641592► Subscribe
Australia661483► Subscribe
Austria180781► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: